# Pre-Approval Expanded Access Study for TAR-200 Treating Physician Use

> **NCT06877676** · — · APPROVED_FOR_MARKETING · sponsor: **Janssen Research & Development, LLC**

## Conditions studied

- Non-Muscle Invasive Bladder Neoplasms

## Interventions

- **DRUG:** TAR-200

## Key facts

- **NCT ID:** NCT06877676
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06877676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06877676, "Pre-Approval Expanded Access Study for TAR-200 Treating Physician Use". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT06877676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*